Health TrialsbyHealthPanel

Effectiveness of an ACT-Based Cognitive Intervention on Quality of Life and Cognitive Function in Elderly Residents With MCI

ConditionMild Cognitive Impairment
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorInstituto de Investigación Marqués de Valdecilla

About this trial

This study investigates the effects of an Acceptance and Commitment Therapy (ACT)-based cognitive intervention on Quality of Life (QOL) and cognitive function among elderly residents with Mild Cognitive Impairment (MCI) in long-term care settings. The study assesses immediate and long-term impacts on cognitive function, psychological flexibility, social engagement, and overall well-being through structured ACT-based training.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Residents aged 65 and older diagnosed with MCI, able to provide informed consent, and residing in participating long-term care facilities.

Disqualifiers

Individuals with severe cognitive impairment, unstable medical conditions, or psychiatric diagnoses that would interfere with participation.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Acceptance and Commitment Therapy (ACT)

    Behavioral

    Acceptance and Commitment Therapy (ACT); Quality of Life (QOL); Mild Cognitive Impairment (MCI); cognitive function; elderly; psychological flexibility.

  • standard care

    Behavioral

    standard care

Treatment groups

215 Participants
are divided into 2 treatment groups
Group A: ACTExperimental treatment 1 intervention
Group B: Standard careActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in Quality of Life as measured by the QOL-AD scale

Quality of Life will be assessed using the QOL-AD scale, a validated questionnaire for evaluating the quality of life in individuals with cognitive impairment. Changes in mean scores from baseline to each time point will be reported

Time frame
Baseline, post-intervention (12 weeks), and 6-month follow-up
2

Change in cognitive function as measured by the Mini-Mental State Examination (MMSE)

Cognitive function will be evaluated using the MMSE, a widely used tool for cognitive assessment. Mean changes in scores from baseline to each time point will be analysed and reported

Time frame
Baseline, post-intervention (12 weeks), and 6-month follow-up

Secondary outcomes

1

Psychological flexibility as measured by the Acceptance and Action Questionnaire (AAQ-II)

Psychological flexibility will be measured using the AAQ-II, a validated scale assessing an individual's ability to engage with values-based actions despite cognitive and emotional challenges. Mean score changes over time will be reported

Time frame
Baseline, post-intervention (12 weeks), and 6-month follow-up
2

Social engagement as measured by a standardised engagement assessment tool

Social engagement will be assessed using a standardised instrument for evaluating participation in meaningful activities and interpersonal connections. Changes in engagement levels will be tracked and reported

Time frame
Baseline, post-intervention (12 weeks), and 6-month follow-up

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Instituto de Investigación Marqués de Valdecilla

Lead sponsor

Source ClinicalTrials.gov
Apply now